Literature DB >> 32002929

Experimental Anxiety Model for Anxiety Disorders: Relevance to Drug Discovery.

Michel Bourin1.   

Abstract

This chapter describes the various animal models that seem relevant to the development of anxiolytic drugs, as well as the human models of induced anxiety, or more precisely the panic inducers including cholecystokinin. It is also mentioned the theoretical model of Deakin and Graeff which seems to keep all its relevance. The knock animals are evoked as relevant tools as well as a new optogenetic technique that needs to be used in this field.

Entities:  

Keywords:  Behavioral models; Knockout mice; Optogenetics; Panic inductors; Theoretical model

Mesh:

Substances:

Year:  2020        PMID: 32002929     DOI: 10.1007/978-981-32-9705-0_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Jie-Yu-He-Huan Capsule Ameliorates Anxiety-Like Behaviours in Rats Exposed to Chronic Restraint Stress via the cAMP/PKA/CREB/BDNF Signalling Pathway.

Authors:  Xiwen Geng; Hongyun Wu; Zifa Li; Chuanfen Li; Dan Chen; Jiancheng Zong; Zimin Liu; Sheng Wei; Wei Peng
Journal:  Oxid Med Cell Longev       Date:  2021-10-04       Impact factor: 6.543

Review 2.  Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action.

Authors:  Mark J Millan
Journal:  Ther Adv Psychopharmacol       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.